ArticleJournal of thoracic disease2026
Age-related outcomes of minimally invasive repair of pectus excavatum: a single-center retrospective cohort study.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pectus excavatum (PE) is the most common congenital deformity of the anterior chest wall. Although minimally invasive repair of pectus excavatum (MIRPE) is widely accepted as the standard surgical approach, the relationship between patient age and postoperative safety remains incompletely defined. This study aimed to examine age-related differences in postoperative effectiveness and complication profiles following MIRPE. Methods: This retrospective cohort study included 719 patients with congenital PE who underwent complete correction using the MIRPE at a single University Medical Center over 8 years. The patients were stratified according to age at surgery as follows: 2-5, 6-11, 12-15, 16-18, and >18 years. Effectiveness was assessed based on clinical improvement, body mass index (BMI), and Haller index (HI), whereas safety was evaluated based on postoperative complication rates. Multivariate logistic regression was performed to estimate adjusted odds ratios (aORs) and confidence intervals (CIs). Results: Mean age of the 719 patients was 12.4±5.7 years. All age groups demonstrated comparable postoperative improvements in clinical status, BMI, and HI (P>0.05). However, complication rates increased with age: 7.6% (2-5 years group), 11.8% (6-11 years group), 15.2% (12-15 years group), 18.1% (16-18 years group), and 21.6% (>18 years group) (P=0.02). Compared with the 2-5 years group, the aOR for each complication was 1.45 (95% CI: 0.63-3.56, P=0.40) for the 6-11 years group, 2.02 (95% CI: 0.93-4.75, P=0.09) for the 12-15 years group, 2.38 (95% CI: 1.09-5.66, P=0.04) for the 16-18 years group, and 3.07 (95% CI: 1.31-7.65, P=0.01) for the >18 years group. Conclusions: Although MIRPE was effective across all age groups, younger patients experienced lower complication rates in this retrospective cohort. These findings should be interpreted as observational and hypothesis-generating rather than prescriptive. Prospective studies and randomized controlled trials remain essential to define evidence-based age recommendations for surgical repair of PE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.